Deadline: 12-Aug-2025
The Canadian Medical Isotope Ecosystem is offering financial support to innovators, developers, and academic institutions in Canada, specifically in the field of radiopharmaceutical and medical isotope technologies.
The funding is designed to expedite the progress of early-stage programs, thereby creating a continuous pipeline for development and eventual commercialization.
Funding Information
- CMIEDF has $5 million to dedicate to advancing medical isotope technologies within Canada. Individual project support will range from $200-500k. CMIEDF will provide a reimbursement up to 50% of eligible project costs when at least 50% of the project is funded by non-federal government sources. Additionally, each project must actively involve at least one small to medium enterprise (SME).
Eligible Projects
- This funding cycle will support radiopharmaceutical and medical isotope technology research programs. They are seeking programs with high impact collaborations that foster business and technology development with enhanced emphasis on commercialization. Eligible programs can be at a Technology Readiness Level (TRL) of 1-9.
- The CMIE is particularly interested in innovative medical isotope technologies that aid in diagnosing and treating rare or difficult-to-treat diseases.
- Additionally, the CMIE Development Fund is not currently accepting proposals for investigational studies or case reports.
Eligibility Criteria
- This application is open to Canadian small to medium enterprises (SMEs), academic institutions, not-for-profit organizations, multi-national enterprises (MNEs), and research institutes. Each project must actively involve at least one SME.
For more information, visit CMIE.